Click here to search courses using NAPNAP's previous Course Catalog layout.

Title
Category
Credits
Event date
Cost
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Contact hours
$25.00
1.25 NAPNAP contact hour, of which 0.5 is Pharmacology and 0.5 Psychopharmacology. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.5 for NAPNAP Members. For non- members, this continuing education activity rate is $25. This session will focus on the increased prevalence of anxiety and depression in children and adolescents in our post-COVID society. The lack of available child psychology and psychiatry services has increased the role of pediatric-focused NPs in providing evidence-based treatment of young patients with these diagnoses throughout the pandemic. Using case-based scenarios and interactive technology, participants will discuss factors impacting symptom presentation and review pharmacologic and non-pharmacologic treatment strategies. Innovative, COVID-friendly mental health resources and coping strategies for children, adolescents and their families will be presented.
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Contact hours
$35.00
1.75 NAPNAP contact hour, of which 1.75 is Pharmacology and 1.75 Psychopharmacology. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $17.5 for NAPNAP Members. For non- members, this continuing education activity rate is $35. This presentation reviews the neurological/biological basis and treatment of psychiatric conditions common to children and adolescents. The presenters will cover the basic anatomy and physiology of the brain to guide a neurological review of common pediatric psychiatric conditions. This knowledge is then used to discuss the pharmacological treatment of psychiatric conditions in the clinical setting.
  • Primary Care
  • Acute Care
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Controlled Substances CE
$90.00
5.25 NAPNAP Contact Hours, 3.75 Pharmacology, 3.75 Psychopharmacology and 0.25 is Controlled substance. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $42 for NAPNAP Members. For non- members, this continuing education activity rate is $90. The bundle will provide a closer look on Neuropsychiatric Medications and The Application in Pediatric Practice , Psychotropic Medications, Effects of Cannabis on Children and Adolescents, Anxiety and Depression through the Waves of COVID-19, and Racial/Ethnic Disparities in Mental Health.
  • FREE for Members
  • Pharmacology CE
  • Contact hours
$10.00
1.0 contact hour of which 1.25 contain pharmacology content. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $10. Clostridioides difficile infection (CDI) is a major public health concern for pediatric and adult patients. The management of pediatric CDI poses a challenge to healthcare providers due to lack of strong randomized controlled trials to guide pharmacological management. Additionally, recent updates to CDI guidelines recommend oral vancomycin over metronidazole for the management of CDI in adults, leaving questions regarding how to best manage pediatric patients. This continuing education pharmacotherapy review describes available evidence for the safety and efficacy of medications used in the treatment and management of pediatric CDI and aims to clarify discrepancies between pediatric and adult recommendations.
  • Primary Care
  • Acute Care
  • FREE for Members
  • Infectious Disease
  • Immunization
  • Pharmacology CE
  • Contact hours
$12.50
1.25 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $12.50. While sharing the latest CDC immunization information, Dr. Koslap-Petraco will share real life experiences and case studies to engage and challenge you to educate and vaccinate your patient families, especially those who question the need for vaccines.
  • Primary Care
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Contact Hour of which 0.25 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. The presenters will address four chronic health conditions that can present challenges to the pediatric-focused NP in a primary care clinic: congenital heart disease, chronic renal failure, post traumatic brain injury and cystic fibrosis. Clinical experts will present the primary care needs of children with medical complexity, which may be different from other children coming to your clinic, including vaccination schedules, medications, developmental considerations and when to call the specialist.
  • Primary Care
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. This presentation will cover the latest research, new medications and updated practice guidelines in pediatric migraine management as well as how to evaluate and use the current evidence in practice.
  • Primary Care
  • FREE for Members
  • Pharmacology CE
  • Contact hours
$10.00
1.0 NAPNAP contact hour, 1.0 pharmacology contact hour. This continuing education activity is offered free to NAPNAP Members. For non-members, this continuing education activity rate is $10. Before 2018, there were no U.S. Food and Drug Administration approved medications for managing seizures in Dravet syndrome (DS). Common agents used in the antiepileptic drug regimens of patients with DS included clobazam, valproic acid, topiramate, and levetiracetam, among others; however, these agents alone rarely provide adequate seizure control. Management of seizures in DS changed in recent years with the approval of cannabidiol and stiripentol in 2018 and fenfluramine in 2020. This continuing education article summarizes available efficacy and safety data involving cannabidiol, stiripentol, and fenfluramine and provides a practical review of dosing strategies, pharmacokinetics, and monitoring interventions relevant to their use. J Pediatr Health Care. (2022) 36, 479−488
  • Acute Care
  • Pharmacology CE
  • Contact hours
$30.00
1.5 NAPNAP Contact Hour, 0.5 Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $15 for NAPNAP Members. For non- members, this continuing education activity rate is $30. Jennifer Joiner is a dual certified pediatric nurse practitioner who serves as the inpatient nurse practitioner for The Children’s Heart Center at the Children’s Hospital of San Antonio for Baylor College of Medicine. Jen has had the privilege of taking care of almost every population of patient in critical care and has been a preceptor and lead of several advanced practice groups. She served as an original test item writer for the PNCB's pilot exam in Acute Care in 2004 and assisted the PNCB by writing acute care pediatric updates for many years.
  • Primary Care
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Penicillin allergy, the most commonly reported allergy in a pediatric patient, is associated with increases in cost of care, hospitalization and morbidity, as well as contributing to antibiotic resistance. However, 95% of patients labeled with a penicillin allergy do not have a true allergy. The Centers for Disease Control & Prevention has identified improper use of antibiotics to be an important factor that must be addressed for both patient safety and public health. This presentation will identify high-risk symptoms of allergy, differentiate between adverse reactions, IgE-mediated allergic reaction and delayed T-cell reactions, as well as discuss appropriate testing for penicillin allergy. Additionally, the presenter will address alternative antibiotics that can be used until a formal allergy evaluation can be completed.

Pages